BlackRock Health Sciences:BME

    Manage Alerts


    As of 9/20/2019

    52 Wk Avg$38.92$37.583.54%
    52 Wk High$43.99$40.0311.00%
    52 Wk Low$32.30$33.61-5.75%
    Regular Distribution TypeManaged Distribution
    Distribution Rate6.23%
    Distribution Amount$0.2000
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Fund seeks current income and capital appreciation through investments in equity securities and derivatives related to health sciences and through utilizing an options strategy

    Capital Structure

    As of 9/20/2019

    Total Net Assets:$354.769M
    Total Common Assets:$354.768M
    Common Shares Outstanding:9,380,449
    Annual Expense Ratios

    As of 12/31/2018

      Per Common Share
    Management Fees1.03%
    Other Expenses:0.10%
    Baseline Expense: 1.12%
    Interest Expense:0.00%
    Total: 1.12%
    Fund Management

    Fund Sponsor
    Blackrock Advisors

    Portfolio Managers
    Christopher M. Accettella (14 Sep 2012) / Kyle McClements (20 Jun 2012) / Dr H. Erin Xie (28 Mar 2005)

    Category: US Equity-Health/Biotech
    Ticker: BME
    NAV Ticker: XBMEX
    Average Daily Volume (shares): 33,000
    Average Daily Volume (USD): $1.286M
    Inception Date: 3/28/2005
    Inception Share Price: $25.00
    Inception NAV: $23.83
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports


    As of 9/20/2019

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 6/30/2019
    Annualized Distribution Rate on NAV:
    As of 9/20/2019
    Total Return on NAV (12 months):
    As of 9/20/2019
    Avg. UNII Per Share:
    As of 6/30/2018
    Total % Portfolio Effectively Leveraged:
    As of 9/20/2019

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 9/20/2019

    PeriodAvg Discount
    6 Month2.06%
    1 Year3.54%
    3 Year2.56%
    5 Year3.38%

    As of 9/20/2019

    3 Month0.50
    6 Month-0.30
    1 Year-0.80
    Pricing History
    Date NAV Premium / Discount


    Calendar Year Total Returns

    As of 9/20/2019
    Category: Health/Biotech

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 9/20/2019
    Category: Health/Biotech

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 3/31/2019
    Annual Portfolio Turnover:
    As of 12/31/2018
    Asset Allocation

    As of 6/30/2017 reported by Fund Sponsor

    Top Sectors

    As of 6/30/2018 reported by Fund Sponsor

    Health Care Equipment & S52.73%
    Pharma, Biotech & Life Sc45.11%
    Cash and/or Derivatives 1.53%
    Consumer Services 0.62%
    Top Holdings

    As of 9/30/2018 reported by Fund Sponsor

    HoldingValue% Portfolio
    UnitedHealth Group Inc$30.81M8.22%
    Pfizer Inc$21.66M5.78%
    Abbott Laboratories$18.55M4.95%
    Medtronic, Inc.$16.81M4.49%
    Boston Scientific, Inc.$16.18M4.32%
    Merck & Co Inc$11.90M3.17%
    WellPoint, Inc.$9.81M2.62%
    Bristol-Myers Squibb Company$9.56M2.55%
    Stryker Corporation$9.52M2.54%
    Johnson & Johnson$9.23M2.46%
    Country Allocation

    As of 6/30/2018 reported by Fund Sponsor

    Country% Portfolio
    USA 91.87%
    Other Countries 3.04%
    UK 2.08%
    Germany 1.81%
    France 1.21%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.


    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.